Quick Heal Technologies Limited Stock Price Today (NSE: QUICKHEAL)

Quick Heal Technologies Limited

140.723.17 (2.20%)
Market Closed

Fundamental Score

...

Quick Heal Technologies Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Quick Heal Technologies Limited share price today is 140.72, down 2.20% on NSE/BSE as of 25 August 2026. Quick Heal Technologies Limited (QUICKHEAL) is a Small-cap company in the Software Products sector with a market capitalisation of 897.35 (Cr). The 52-week high for QUICKHEAL share price is 371.40 and the 52-week low is 125.00. 0

Quick Heal Technologies Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
164.79
Low
140.72
Volume
53.4K
Change
-10.64%

Quick Heal Technologies Limited share price chart: -10.64% return over the past month. 52-week high ₹371.40, 52-week low ₹125.00.

Quick Heal Technologies Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
139.30141.90139.30140.7236.16K (Cr)
151.30151.30143.00143.8991.96K (Cr)
150.00152.99148.20149.0940.49K (Cr)
150.00151.90148.00149.5033.60K (Cr)
153.90153.90148.00149.6628.13K (Cr)
150.89151.99150.00151.3632.54K (Cr)
157.49157.49148.10151.1776.12K (Cr)
152.65157.00152.65155.0222.88K (Cr)
156.60158.00154.00155.6533.41K (Cr)
159.50159.50152.00154.7040.35K (Cr)

Quick Heal Technologies Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
153.00164.75139.30140.72-8.03%
173.47174.99151.00152.88-11.87%
186.90196.50163.00170.75-8.64%
166.58243.25162.42186.02+11.67%
129.99175.00128.07166.58+28.15%
159.00163.26125.00125.53-21.05%
183.00204.00164.60166.37-9.09%
265.00272.20182.00187.50-29.25%
310.50320.75257.95265.75-14.41%
318.50337.00295.55307.45-3.47%
302.00371.40297.75317.50+5.13%
290.00351.70287.05301.40+3.93%

AI Research Briefing

Powered by Gemini · 2026-04-10

Quick Heal is a binary bet on whether they can ditch consumer antivirus and become an enterprise cybersecurity player.

Research Confidence
6.0/10Moderate
TURNAROUNDPrice is down 12.48% over the last 6 months and 50.54% over the last year [cite: brief].P/E is non-existent, while the industry P/E is 36.75x [cite: brief]. Valuation is difficult to assess due to current losses.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Quick Heal's trading window closed on April 1, 2026, ahead of the FY26 results. The window will reopen 48 hours after the results are announced. On March 18, 2026, NSE and BSE approved the reclassification of Gagan Bharari Enterprises LLP from the promoter group to the public category. Quick Heal also allotted 18,015 equity shares under its ESOP Scheme 2021 on February 27, 2026.

CORE STORY (THE REAL GAME)

Quick Heal is attempting a pivot from a consumer antivirus play to an enterprise cybersecurity and data privacy solutions provider, leveraging government contracts and DPDP compliance tailwinds. The market is watching if they can execute this transition.

Why Now
  • Enterprise segment showing growth
  • Government contracts providing a base
  • DPDP compliance creating a new market
Potential Catalysts
  • Significant new enterprise contract wins
  • Successful launch and adoption of DPDP compliance solutions
  • Turnaround in consumer segment
Key Risks
  • Micro-cap with liquidity risk
  • Negative ROE and ROCE
  • High promoter holding limits float
Institutional Activity

Promoter holding is high at 71.63%, with a slight decrease of 0.16% [cite: brief]. FII and DII holdings are low and decreasing [cite: brief].

Macro Context

Indian software market is growing, with cybersecurity being a key area.

Order Book / Expansion

Secured a ₹64.25 Cr contract with NFSU Research and Innovation Council. Order book exceeds INR 80 Cr.

Cash Flow Quality

Free cash flow is positive at ₹175.68 Cr over the last 5 years [cite: brief].

3–6 Month Outlook

The next 3-6 months will be critical in determining if Quick Heal can sustain its enterprise growth and capitalize on the DPDP opportunity. Failure to do so will likely lead to further downside.

Primary Thesis Risk

Inability to successfully transition to an enterprise-focused cybersecurity business will lead to significant value erosion.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

0.00%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

-4.62%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

7.94%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Quick Heal Technologies Limited Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

34.85x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

71.63%

% shares held by company founders/management

Poor

FII Holding

0.73%

% shares held by foreign institutional investors

Poor

DII Holding

1.16%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Profit Growth (Quarterly YoY)

N/A

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-21.39%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

-4.76%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

-102.20x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

74.74 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Quick Heal Technologies Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of QUICKHEAL across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Healthy Liquidity Position (Current Ratio: 3.40)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Strong Cash Generation (₹74.74 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (71.63%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

7 factors identified

Below-Average Return on Equity (0.00%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (-4.62%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Revenue Contraction (-21.39%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Limited Growth History (-4.76% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Interest Coverage (-102.20x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Limited Institutional Interest (FII+DII: 1.89%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Quick Heal Technologies Limited vs Software Products Peers

Peer Comparison - Software Products

Compare Quick Heal Technologies Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
14.2/100
141
₹897.35
0.00%
Poor
-4.62%
Poor
0.0
Excellent
-4.76%
Poor
0.00%
63.3/100
11623
₹101190.51
29.6
Average
32.61%
Excellent
42.09%
Excellent
0.0
Excellent
8.42%
Good
9.01%
Good
3.44%
65.5/100
577
₹7484.41
14.0
Average
21.41%
Excellent
26.31%
Excellent
0.0
Excellent
7.41%
Good
13.54%
Good
2.13%
59.2/100
1013
₹6444.54
46.8
Average
15.82%
Good
22.87%
Excellent
0.0
Excellent
0.30%
48.2/100
565
₹3060.85
73.8
Average
12.57%
Average
12.48%
Average
0.0
Excellent
-5.59%
Poor
2.28%
Average
0.00%
43.2/100
1181
₹2424.83
82.6
Average
55.54%
Excellent
75.89%
Excellent
0.1
Excellent
0.06%
47.2/100
712
₹2011.39
19.1
Average
13.56%
Average
16.32%
Good
0.0
Excellent
-0.21%
Poor
11.27%
Good
1.64%
21.6/100
23
₹1994.78
0.00%
21.9/100
88
₹965.01
62.4
Average
15.55%
Good
19.96%
Good
0.0
Excellent
0.00%
29.7/100
16
₹757.62
76.3
Average
8.82%
Poor
9.84%
Poor
0.0
Excellent
-5.59%
Poor
0.00%
61.9/100
250
₹520.06
4.1
Average
91.53%
Excellent
12.24%
Average
0.0
Excellent
0.00%

Quick Heal Technologies Limited PE Ratio History

Historical price-to-earnings ratio for QUICKHEAL — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20250.94₹265.75282.7x
FY 20244.48₹656.00146.4x
FY 20231.14₹361.40317x
FY 202213.94₹174.9012.5x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Quick Heal Technologies Limited Dividend History

Annual cash dividends paid by QUICKHEAL — dividend yield N/A

Financial YearDividends Paid (₹ Cr)
FY 202516.13 Cr
FY 202413.29 Cr
FY 202326.09 Cr
FY 202223.15 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Quick Heal Technologies Limited Quarterly Performance

Latest quarterly metrics for QUICKHEAL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-21.39%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

N/A

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

-4.76%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Quick Heal Technologies Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for QUICKHEAL — calculated from daily price history

31RSI 14
Neutral — RSI 31

Momentum is balanced — neither overbought nor oversold.

SMA 50
166
▼ Price below SMA 50 — Short-term bearish
SMA 200
207
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
52K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Quick Heal Technologies Limited Financial Statements

Annual income statement, balance sheet and cash flow for Quick Heal Technologies Limited (QUICKHEAL) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Quick Heal Technologies Limited

Loading latest quarterly results...

About QUICKHEAL (Quick Heal Technologies Limited)

Quick Heal Technologies Ltd is a pioneering force in the cybersecurity landscape, dedicated to safeguarding digital ecosystems through innovative and robust software solutions. The... company crafts a comprehensive suite of security products designed to shield a diverse clientele, ranging from individual home users to sprawling multinational corporations. Quick Heal's mission is to empower users with the tools they need to navigate the ever-evolving threat landscape with confidence, providing a shield against malware, phishing attacks, and other sophisticated cyber threats. They are deeply committed to providing top tier security for their customers. At the core of Quick Heal's offerings lies a commitment to providing effective and user-friendly protection. Their product line boasts a spectrum of solutions, each meticulously crafted to address specific security needs. From their flagship antivirus suite, renowned for its real-time threat detection capabilities, to their specialized mobile security solutions, Quick Heal equips users with a multi-layered defense against the digital perils of today. They develop security software to serve the customer's best interests. Quick Heal Technologies is a global company that has been offering solutions for many years. Beyond its core product offerings, Quick Heal is dedicated to continuous research and development, constantly adapting its technologies to stay ahead of emerging threats. They maintain a dedicated team of cybersecurity experts who actively monitor the threat landscape, analyzing new vulnerabilities and developing innovative countermeasures. This proactive approach ensures that Quick Heal's users remain protected against the latest and most sophisticated cyberattacks, solidifying its position as a trusted leader in the cybersecurity industry.

Company Details

Symbol:QUICKHEAL
Industry:Software Products
Sector:Software Products

Key Leadership

Dr. Kailash Sahebrao Katkar
Co-Founder, Chairman of the Board & MD
Dr. Sanjay Sahebrao Katkar
Co-Founder, Joint MD & Director
Mr. Ankit Maheshwari
Chief Financial Officer

QUICKHEAL Share Price: Frequently Asked Questions

What is the current share price of Quick Heal Technologies Limited?

Quick Heal Technologies Limited (QUICKHEAL) trades at ₹140.72 on NSE and BSE. Market cap ₹897.35 (Cr). Educational data only.

What is the P/E ratio of Quick Heal Technologies Limited?

Quick Heal Technologies Limited has a P/E of N/Ax vs industry average 34.85x.

What is the Bull Run score for Quick Heal Technologies Limited?

Quick Heal Technologies Limited has a Bull Run score of 14.2/100 based on 25+ financial parameters.

Does Quick Heal Technologies Limited pay dividends?

Quick Heal Technologies Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Quick Heal Technologies Limited?

Quick Heal Technologies Limited has ROE of 0.00%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Quick Heal Technologies Limited?

Quick Heal Technologies Limited has debt-to-equity of 0.00.

Is Quick Heal Technologies Limited a good investment?

Bull Run gives Quick Heal Technologies Limited a score of 14.2/100. This is not investment advice — consult a SEBI-registered advisor.